CLC number: R512.99
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2020-04-14
Cited: 0
Clicked: 5509
Jiang-shan Lian, Huan Cai, Shao-rui Hao, Xi Jin, Xiao-li Zhang, Lin Zheng, Hong-yu Jia, Jian-hua Hu, Shan-yan Zhang, Guo-dong Yu, Jue-qing Gu, Chan-yuan Ye, Ci-liang Jin, Ying-feng Lu, Ji-fang Sheng, Yi-da Yang. Comparison of epidemiological and clinical characteristics of COVID-19 patients with and without Wuhan exposure history in Zhejiang Province, China[J]. Journal of Zhejiang University Science B, 2020, 21(5): 369-377.
@article{title="Comparison of epidemiological and clinical characteristics of COVID-19 patients with and without Wuhan exposure history in Zhejiang Province, China",
author="Jiang-shan Lian, Huan Cai, Shao-rui Hao, Xi Jin, Xiao-li Zhang, Lin Zheng, Hong-yu Jia, Jian-hua Hu, Shan-yan Zhang, Guo-dong Yu, Jue-qing Gu, Chan-yuan Ye, Ci-liang Jin, Ying-feng Lu, Ji-fang Sheng, Yi-da Yang",
journal="Journal of Zhejiang University Science B",
volume="21",
number="5",
pages="369-377",
year="2020",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2000112"
}
%0 Journal Article
%T Comparison of epidemiological and clinical characteristics of COVID-19 patients with and without Wuhan exposure history in Zhejiang Province, China
%A Jiang-shan Lian
%A Huan Cai
%A Shao-rui Hao
%A Xi Jin
%A Xiao-li Zhang
%A Lin Zheng
%A Hong-yu Jia
%A Jian-hua Hu
%A Shan-yan Zhang
%A Guo-dong Yu
%A Jue-qing Gu
%A Chan-yuan Ye
%A Ci-liang Jin
%A Ying-feng Lu
%A Ji-fang Sheng
%A Yi-da Yang
%J Journal of Zhejiang University SCIENCE B
%V 21
%N 5
%P 369-377
%@ 1673-1581
%D 2020
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2000112
TY - JOUR
T1 - Comparison of epidemiological and clinical characteristics of COVID-19 patients with and without Wuhan exposure history in Zhejiang Province, China
A1 - Jiang-shan Lian
A1 - Huan Cai
A1 - Shao-rui Hao
A1 - Xi Jin
A1 - Xiao-li Zhang
A1 - Lin Zheng
A1 - Hong-yu Jia
A1 - Jian-hua Hu
A1 - Shan-yan Zhang
A1 - Guo-dong Yu
A1 - Jue-qing Gu
A1 - Chan-yuan Ye
A1 - Ci-liang Jin
A1 - Ying-feng Lu
A1 - Ji-fang Sheng
A1 - Yi-da Yang
J0 - Journal of Zhejiang University Science B
VL - 21
IS - 5
SP - 369
EP - 377
%@ 1673-1581
Y1 - 2020
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2000112
Abstract: Background: A novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in wuhan, China, has been rapidly spreading around the world. This study investigates the epidemiological and clinical characteristics of coronavirus disease 2019 (COVID-19) patients in zhejiang Province who did or did not have a history of wuhan exposure. Methods: We collected data from medical records of confirmed COVID-19 patients in zhejiang Province from Jan. 17 to Feb. 7, 2020 and analyzed epidemiological, clinical, and treatment data of those with and without recorded recent exposure in wuhan. Results: Patients in the control group were older than those in the exposure group ((48.19±16.13) years vs. (43.47±13.12) years, P<0.001), and more were over 65 years old (15.95% control vs. 5.60% exposure, P<0.001). The rate of clustered onset was also significantly higher in the control group than in the exposure group (31.39% vs. 18.66%, P<0.001). The symptom of a sore throat in patients in the exposure group was significantly higher than that in the control group (17.30% vs. 10.89%, P=0.01); however, headache in the exposure group was significantly lower than that in the control group (6.87% vs. 12.15%, P=0.015). More patients in the exposure group had a significantly lower level of lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) than those in the control group. There was no significant difference in any degree of COVID-19 including mild, severe, and critical between the two groups. Conclusions: From the perspective of epidemiological and clinical characteristics, there was no significant difference between COVID-19 patients with and without wuhan exposure history.
[1]Chen NS, Zhou M, Dong X, et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223):507-513.
[2]Deng LH, Zeng YL, Feng P, et al., 2012. Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu, China. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 13(1):49-55.
[3]Goka EA, Vallely PJ, Mutton KJ, et al., 2014. Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence. Arch Virol, 159(12):3167-3183.
[4]Huang CL, Wang YM, Li XW, et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506.
[5]Li Q, Guan XH, Wu P, et al., 2020. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 382:1199-1207.
[6]Otte A, Sauter M, Daxer MA, et al., 2015. Adaptive mutations that occurred during circulation in humans of H1N1 influenza virus in the 2009 pandemic enhance virulence in mice. J Virol, 89(14):7329-7337.
[7]Vazquez-Perez JA, Isa P, Kobasa D, et al., 2013. A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in Mexico. Virol J, 10:41.
[8]Wang DW, Hu B, Hu C, et al., 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 323(11):1061-1069.
[9]WHO (World Health Organization), 2020. Clinical management of severe acute respiratory infection when COVID-19 is suspected: interim guidance. https://www.who.int/ publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected [Accessed on Jan. 30, 2020].
[10]Wong G, He SH, Leung A, et al., 2019. Naturally occurring single mutations in Ebola virus observably impact infectivity. J Virol, 93(1):e01098-18.
[11]Wu JT, Leung K, Leung GM, 2020. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet, 395(10225):689-697.
[12]Wu ZY, McGoogan JM, 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 323(13):1239-1242.
[13]Xu LL, Bao LL, Li FD, et al., 2011. Adaption of seasonal H1N1 influenza virus in mice. PLoS ONE, 6(12):e28901.
[14]Yang XB, Yu Y, Xu JQ, et al., 2020. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med, in press.
[15]Zhu N, Zhang DY, Wang WL, et al., 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 382(8):727-733.
Open peer comments: Debate/Discuss/Question/Opinion
<1>